Roche · 1 day ago
2026 Summer Intern - Pathology Chemistry
Roche is a global healthcare company dedicated to advancing science and improving access to healthcare. The 2026 Summer Intern in Pathology Chemistry will work with chemists to design and test new reagents for cancer tissue diagnostics, contributing to innovative solutions in the field of tissue diagnostics.
BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
Responsibilities
Work with chemists to design new reagents and formulations for cancer tissue diagnostics
Synthesize, characterize and/or test novel reagents on automated tissue stainers
Troubleshoot reagent issues as part of a project team
Use analytical methods to validate quality and assess functionality
Qualification
Required
Must be pursuing a Master's Degree (enrolled student)
Must be pursuing a PhD (enrolled student)
Required majors: Chemistry or Biochemistry
Experience in a chemistry wet lab
Strong adherence to lab safety
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Familiarity with chemical and protein purification techniques
Knowledge and experience in instrumental analytics (e.g. UV-Vis, HPLC)
Document work in electronic notebooks utilizing ChemDraw
Benefits
Paid holiday time off benefits
Company
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.
H1B Sponsorship
Roche has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (9)
2023 (6)
2022 (2)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$7.79BKey Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M
Leadership Team
Recent News
2026-02-03
2026-02-03
Company data provided by crunchbase